Comparative Efficacy of Dopamine Partial Agonists by Doses for Treatment-Resistant Depression: A Systematic Review and Dose-Response Model-Based Network Meta-analysis.

Published in: Journal of clinical psychopharmacology (2024)

Aripiprazole, brexpiprazole, and cariprazine may be effective in treatment-resistant depression in that order, with the maximum effective doses at 5.5 mg, 1.6 mg, and 1.5 mg, respectively.

Keyphrases

systematic review
depressive symptoms
sleep quality
major depressive disorder
meta analyses
metabolic syndrome
randomized controlled trial
bipolar disorder
network analysis